Education
About Us
Working with TipRanks
Follow Us
908 Devices (MASS)
NASDAQ:MASS
MASS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.81 - $8.06
Previous CloseN/A
Volume74.64K
Average Volume (3M)290.51K
Market Cap
$235.64M
Enterprise Value$141.66M
Total Cash (Recent Filing)$118.58M
Total Debt (Recent Filing)$4.43M
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Nov 18, 2025EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding36,085,697
10 Day Avg. Volume366,057
30 Day Avg. Volume290,510
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.60
Enterprise Value/Revenue2.35
Enterprise Value/Gross Profit4.83
Enterprise Value/Ebitda-2.33
Forecast
1Y Price Target
$9.75Price Target Upside33.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSecond-quarter results came in ahead of expectations across the board, and guidance was raised commensurate with the beat.
Market PositionMASS has turned into a forensics and threat detection pure-play that is positioned to see upside to their 20%+ growth expectations as the One Big Beautiful Act releases funds for enforcement, security, drug and broader threat detection.
Product InnovationMASS is fundamentally a technology innovator in these markets and will continue to drive growth from new handheld products beyond the core MX908 device.
Bears Say
Market ValuationShares trade at 2.0 times the midpoint of guidance for 2025 revenue from continuing operations, and the stock is rated Outperform.
Operational ChangesPost-desktop divestment, the company has a leaner and more focused product lineup, reducing exposure to broader macro funding headwinds.
908 Devices News
MASS FAQ
What was 908 Devices’s price range in the past 12 months?
908 Devices lowest stock price was $1.81 and its highest was $8.06 in the past 12 months.
What is 908 Devices’s market cap?
908 Devices’s market cap is $235.64M.
When is 908 Devices’s upcoming earnings report date?
908 Devices’s upcoming earnings report date is Nov 18, 2025 which is in 59 days.
How were 908 Devices’s earnings last quarter?
908 Devices released its earnings results on Aug 05, 2025. The company reported -$0.36 earnings per share for the quarter, missing the consensus estimate of -$0.17 by -$0.19.
Is 908 Devices overvalued?
According to Wall Street analysts 908 Devices’s price is currently Undervalued.
Does 908 Devices pay dividends?
908 Devices does not currently pay dividends.
What is 908 Devices’s EPS estimate?
908 Devices’s EPS estimate is -0.14.
How many shares outstanding does 908 Devices have?
908 Devices has 36,085,697 shares outstanding.
What happened to 908 Devices’s price movement after its last earnings report?
908 Devices reported an EPS of -$0.36 in its last earnings report, missing expectations of -$0.17. Following the earnings report the stock price went down -2.761%.
Which hedge fund is a major shareholder of 908 Devices?
Currently, no hedge funds are holding shares in MASS
908 Devices Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.75 (33.56% Upside)
$9.75 (33.56% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Increased
By 18.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
84.82%
12-Months-Change
Fundamentals
Return on Equity
-46.85%
Trailing 12-Months
Asset Growth
-8.18%
Trailing 12-Months
Company Description
908 Devices
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
MASS Company Deck
MASS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a positive outlook with significant revenue growth, strategic product launches, and improved operational efficiencies. However, these positives were offset by increased operating expenses and a decline in gross margin. Despite these challenges, the company's strategic initiatives and legislative support provide a promising outlook.View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
$9.75
▲(33.56% Upside)
Technical Analysis
Ownership Overview
24.98% Insiders
11.94% Mutual Funds
0.60% Other Institutional Investors
43.45% Public Companies and
Individual Investors